Notice to stakeholders - Release of Guidance Document for consultation: Regulation of Fecal Microbiota Therapy for the Treatment of C. difficile Infections
Notice to the reader:
The online consultation is now closed.
Health Canada announces the release of theGuidance document Regulation of Fecal Microbiota Therapy for the Treatment of C. difficile Infections. Health Canada invites all interested stakeholders to submit their feedback during the 30-day comment period from March 30, 2015 to April 30, 2015.
Instructions to Participate in Consultation
Comments on the Guidance document should be submitted to Health Canada, preferably in electronic format, within 30 days from the date of this notice in order to allow sufficient time for their assessment.
To submit comments to Health Canada
- Please email comments to BGTD.OPIC@hc-sc.gc.ca. All comments will be considered in the finalization of the guidance.
- Comments will also be accepted by
Office of Policy and International Collaboration
Biologics and Genetic Therapies Directorate
Health Products and Food Branch
100 Eglantine Driveway
Ottawa ON K1A 0K9
Address Locator: 0601B
- Date modified: